-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
CONMED (NASDAQ:CNMD) Downgraded by StockNews.com to Sell
CONMED (NASDAQ:CNMD) Downgraded by StockNews.com to Sell
StockNews.com downgraded shares of CONMED (NASDAQ:CNMD – Get Rating) from a hold rating to a sell rating in a research note published on Monday morning.
CONMED Trading Down 3.5 %
Shares of CNMD stock opened at $96.53 on Monday. The stock has a 50-day moving average price of $99.43. The company has a debt-to-equity ratio of 1.46, a current ratio of 2.87 and a quick ratio of 1.43. CONMED has a 12 month low of $87.24 and a 12 month high of $159.11.
Get CONMED alerts:CONMED (NASDAQ:CNMD – Get Rating) last announced its quarterly earnings data on Wednesday, May 4th. The company reported $0.70 EPS for the quarter, topping analysts' consensus estimates of $0.62 by $0.08. The firm had revenue of $242.33 million during the quarter, compared to analyst estimates of $235.55 million. CONMED had a positive return on equity of 13.94% and a negative net margin of 10.93%. Equities analysts forecast that CONMED will post 3.32 EPS for the current fiscal year.
About CONMED
(Get Rating)CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries.
Featured Articles
- Get a free copy of the StockNews.com research report on CONMED (CNMD)
- 3 Hotel Stocks to Consider Checking into After Earnings
- How Does Freeport McMoran Inc Compare to Its Sector Competitors?
- Can FuelCell Energy Surge Higher This Year?
- Is It Time to Take a Ride on Cedar Fair Stock?
- Time To Take A Serious Look At Nikola Stock As Production Starts
Receive News & Ratings for CONMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED and related companies with MarketBeat.com's FREE daily email newsletter.
StockNews.com downgraded shares of CONMED (NASDAQ:CNMD – Get Rating) from a hold rating to a sell rating in a research note published on Monday morning.
斯托克新闻网在周一上午发布的一份研究报告中将CONMED(纳斯达克代码:CNMD-GET Rating)的股票评级从持有评级下调至卖出评级。
CONMED Trading Down 3.5 %
ConMed股价下跌3.5%
Shares of CNMD stock opened at $96.53 on Monday. The stock has a 50-day moving average price of $99.43. The company has a debt-to-equity ratio of 1.46, a current ratio of 2.87 and a quick ratio of 1.43. CONMED has a 12 month low of $87.24 and a 12 month high of $159.11.
CNMD股票周一开盘报96.53美元。该股的50日移动均价为99.43美元。该公司的债务权益比为1.46,流动比率为2.87,速动比率为1.43。ConMed的12个月低点为87.24美元,12个月高位为159.11美元。
CONMED (NASDAQ:CNMD – Get Rating) last announced its quarterly earnings data on Wednesday, May 4th. The company reported $0.70 EPS for the quarter, topping analysts' consensus estimates of $0.62 by $0.08. The firm had revenue of $242.33 million during the quarter, compared to analyst estimates of $235.55 million. CONMED had a positive return on equity of 13.94% and a negative net margin of 10.93%. Equities analysts forecast that CONMED will post 3.32 EPS for the current fiscal year.
康美德(纳斯达克代码:CNMD-GET Rating)上一次公布季度收益数据是在5月4日星期三。该公司公布本季度每股收益为0.70美元,比分析师普遍预期的0.62美元高出0.08美元。该公司本季度营收为2.4233亿美元,而分析师预期为2.3555亿美元。ConMed的股本回报率为正13.94%,净利润率为负10.93%。股票分析师预测,CONMED本财年每股收益将达到3.32欧元。
About CONMED
关于CONMED
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries.
康美德公司是一家医疗技术公司,在全球范围内开发、制造和销售外科手术器械和相关设备。它提供整形外科产品,包括带有Y-Knot All-in-One软组织固定系统的TruShott、Y-Knot All-Sture Anchors和PopLok Nnotless缝合Anchors,这些产品为整形外科医生修复软组织损伤提供了独特的临床解决方案,以及使外科医生能够进行微创运动医学手术的配套产品。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on CONMED (CNMD)
- 3 Hotel Stocks to Consider Checking into After Earnings
- How Does Freeport McMoran Inc Compare to Its Sector Competitors?
- Can FuelCell Energy Surge Higher This Year?
- Is It Time to Take a Ride on Cedar Fair Stock?
- Time To Take A Serious Look At Nikola Stock As Production Starts
- 免费获取StockNews.com关于CONMED的研究报告(CNMD)
- 盈利后考虑登记的3家酒店股票
- 自由港麦克莫兰公司与其行业竞争对手相比如何?
- 燃料电池能源今年会飙升吗?
- 是时候在雪松公平股票上兜风了吗?
- 随着生产开始,是时候认真看看尼古拉·斯托克了
Receive News & Ratings for CONMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED and related companies with MarketBeat.com's FREE daily email newsletter.
接受CONMED日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对CONMED和相关公司的最新新闻和分析师评级的每日简明摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧